Did not become law. It stopped in the House of Representatives's Judiciary Committee on April 1, 2016. The 2016 session has ended.
2016 Regular Session
House Bill 5270
AN ACT CONCERNING THE RIGHT TO TRY EXPERIMENTAL DRUGS.
What it does
The synopsis the General Assembly published with the bill.
To allow eligible patients to try investigational drugs, biological products or devices.
Sponsors
Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.
In the House of Representatives
Sponsor
6 co-sponsors
David Zoni, Henry J. Genga, Vincent J. Candelora, Gayle J. Mulligan, Philip J. Miller, Theresa W. Conroy
In the Senate
4 co-sponsors
Its course
February 17 to April 1, 2016, on one scale. In the top row each mark is a day something happened; taller marks are busier days.
Each committee stop sits inside its chamber.
Every action10 actions on 7 days
In the House of RepresentativesFeb 17 to Apr 1 · stopped44 days
Public Health CommitteeFeb 17 to Mar 719 days
Judiciary CommitteeApr 1 to Apr 1 · stopped0 days
Text
Each version as the General Assembly printed it.
l9n doesn't hold this bill's text yet.
What happened
In l9n's words, one line for each step. Every action as the General Assembly published it is below.
In the House of Representatives Feb 17 – Apr 1
- Feb 17Introduced and sent to Public Health Committee
- Feb 19Heard in Public Health Committee
- Mar 7Public Health Committee recommended it
- Apr 1Sent to Judiciary Committee
All 10 actions, as published
- Feb 17REF. TO JOINT COMM. ONBoth houses
- Feb 19PUBLIC HEARINGBoth houses
- Mar 7Joint FavorableBoth houses
- Mar 8FILED WITH LCOBoth houses
- Mar 16REFERRED TO OLR, OFABoth houses
- Mar 22RPTD. OUT OF LCOBoth houses
- Mar 22FAV. RPT., TABLED FOR HOUSE CALENDARHouse of Representatives
- Mar 22HOUSE CALENDAR NUMBERHouse of Representatives
- Mar 22FILE NO.Both houses
- Apr 1REF. BY HOUSE TO COMMITTEE ONHouse of Representatives